Please use this identifier to cite or link to this item:
|Title:||Managing lupus patients during pregnancy|
|Authors:||Lateef, A. |
Neonatal lupus syndromes
Systemic lupus erythematosus
|Source:||Lateef, A.,Petri, M. (2013-06). Managing lupus patients during pregnancy. Best Practice and Research: Clinical Rheumatology 27 (3) : 435-447. ScholarBank@NUS Repository. https://doi.org/10.1016/j.berh.2013.07.00511|
|Abstract:||Systemic lupus erythematosus (SLE) is an auto-immune disease, primarily affecting young females. Pregnancy in a woman with SLE remains a high-risk situation with higher maternal and foetal mortality and morbidity. Although live births are achieved in majority of the pregnancies, active disease and major organ involvement can negatively affect the outcomes. A higher risk of foetal loss, pre-term birth, intra-uterine growth restriction (IUGR) and neonatal lupus syndromes (NLSs) are major foetal issues. Mothers are faced with disease flares, pre-eclampsia and other complications. Disease flares during SLE pregnancy pose the unique issue of recognition and differentiation between physiologic changes and disease state. Similarly, pre-eclampsia and lupus nephritis may lead to diagnostic confusion. Treatment choices during pregnancy are limited to a few safe drugs, further restricting the options. Refractory pregnancy loss associated with anti-phospholipid antibodies (aPLs) and complete heart block associated with anti-Ro antibodies remain unresolved issues. A multidisciplinary approach, with close monitoring, is essential for optimal outcomes. © 2013 Elsevier Ltd. All rights reserved.|
|Source Title:||Best Practice and Research: Clinical Rheumatology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 10, 2018
checked on Jan 19, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.